Axa S.A. Immunome Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Immunome Inc. stock. As of the latest transaction made, Axa S.A. holds 179,519 shares of IMNM stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

179,519

Previous 179,232 0.16%

Holding current value

$2.88 Million

Previous $1.21 Million 38.39%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.56 - $9.79 $1,595 - $2,809	287 Added 0.16%	179,519 $1.67 Million
Q1 2025 May 15, 2025	SELL	$6.73 - $11.83 $1,520 - $2,673	-226 Reduced 0.13%	179,232 $1.21 Million
Q4 2024 Feb 14, 2025	SELL	$9.11 - $14.53 $2,578 - $4,111	-283 Reduced 0.16%	179,458 $1.84 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $16.51 $620 - $875	53 Added 0.03%	179,741 $2.63 Million
Q2 2024 Feb 25, 2025	BUY	$11.54 - $22.11 $2,654 - $5,085	230 Added 0.13%	179,688 $2.17 Million
Q2 2024 Aug 14, 2024	BUY	$11.54 - $22.11 $2.07 Million - $3.97 Million	179,688 New	179,688 $2.17 Million

Others Institutions Holding IMNM

# of Institutions

150

Shares Held

66.6M

Call Options Held

44.9K

Put Options Held

4.24M

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $195M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account